☰

Rouba Kozak

Affiliations: 
Pfizer, Inc., San Diego, CA, United States 
Area:
Neuropsychopharmacology
Website:
http://www.pfizer.com/pfizer/main.jsp
Google:
"Rouba Kozak"
Mean distance: 15.63 (cluster 19)
 
Cross-listing: PsychTree

Tree Publications Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

Parents

Sign in to add mentor
Martin Sarter post-doc 2003-2006 University of Michigan

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Moore TL, Young DA, Killiany RJ, et al. (2021) The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey. Frontiers in Aging Neuroscience. 13: 757850
Kozak R, Kiss T, Dlugolenski K, et al. (2020) Characterization of PF-6142, a Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman Primate Models of Dopaminergic Activation. Frontiers in Pharmacology. 11: 1005
Balice-Gordon R, Honey GD, Chatham C, et al. (2020) A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity. The International Journal of Neuropsychopharmacology
Young D, Popiolek M, Trapa P, et al. (2020) D1 agonist improved movement of parkinsonian nonhuman primates with limited dyskinesia side effects. Acs Chemical Neuroscience
Soutschek A, Kozak R, de Martinis N, et al. (2020) Activation of D1 receptors affects human reactivity and flexibility to valued cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Arce E, Balice-Gordon R, Duvvuri S, et al. (2019) A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia. Journal of Psychopharmacology (Oxford, England). 269881119855302
Wang M, Datta D, Enwright J, et al. (2019) A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex. Neuropharmacology
Davoren JE, Nason DM, Coe J, et al. (2018) Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. Journal of Medicinal Chemistry
Gilmour G, Porcelli S, Bertaina-Anglade V, et al. (2018) Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection. Neuroscience and Biobehavioral Reviews
Popiolek M, Mandelblat-Cerf Y, Young D, et al. (2018) In vivo modulation of hippocampal excitability by M4 muscarinic acetylcholine receptor activator: implications for treatment of Alzheimer's disease and schizophrenic patients. Acs Chemical Neuroscience
See more...